RIS

Planet Reports Financial Results for First Quarter of Fiscal 2024

Retrieved on: 
Thursday, June 8, 2023
Technology, Satellite, Photography, Professional Services, Audio, Video, Software, Data Analytics, Data Management, Artificial Intelligence, Intelligence, Climate, EOP, Classification, ERM, Microsoft, GAAP, Environmental resource management, Capital expenditure, Investment, INRA, EO, NYSE, Automation, United Arab Emirates Space Agency, Defense, SFS, Policy, RIS, Risk, Welsh, Government, Net, Growth, Conference, Fiscal, International, CAP, Syntheta, Climate change, Webcast, MSFT, Depreciation, Adjustment, NEO, Partnership, Welsh Government, Syngenta, RVO, EBITDA, AI, Ballistics, United Arab Emirates, Cryptocurrency, Bank, Video game, Fine chemical, Risk management, Medical device, Planet, SkySat

First quarter gross margin expanded to 53%, compared to 41% in the first quarter of fiscal year 2023.

Key Points: 
  • First quarter gross margin expanded to 53%, compared to 41% in the first quarter of fiscal year 2023.
  • First quarter Non-GAAP Gross Margin(1) expanded to 56%, compared to 45% in the first quarter of fiscal year 2023.
  • (1) Please see “Planet’s Use of Non-GAAP Financial Measures” below for a discussion on how Planet calculates the non-GAAP financial measures presented herein.
  • The actual amount of these expenses during the first quarter of fiscal year 2024 and fiscal year 2024 will have a significant impact on Planet’s future GAAP financial results.

TMYTEK Unveils the XRifle Reflector Solution for Wider FR2 Extension and Effective 5G mmWave Coverage at Wireless Japan 2023

Retrieved on: 
Thursday, May 25, 2023
High-pass filter, Communication, SDR, TMY, Exhibition, Challenge, 5G, RIS, Research, URLLC, Incidence, FR2, GNB, Hospital, NI, UE, Wireless, Mobile phone, Bbox

TAIPEI, May 25, 2023 /PRNewswire/ -- TMY Technology Inc. (TMYTEK), a leading provider of millimeter-wave solutions, will showcase their latest innovations, the XRifle Reflector and 5G mmW-Coverage solution, at the distinguished Wireless Japan 2023 exhibition in Tokyo (Booth #W-16).

Key Points: 
  • TAIPEI, May 25, 2023 /PRNewswire/ -- TMY Technology Inc. (TMYTEK), a leading provider of millimeter-wave solutions, will showcase their latest innovations, the XRifle Reflector and 5G mmW-Coverage solution, at the distinguished Wireless Japan 2023 exhibition in Tokyo (Booth #W-16).
  • These cutting-edge technologies offer an optimal solution for 5G FR2 research in laboratory environments and seamless deployment of base stations in the field.
  • TMYTEK is excited to collaborate with their esteemed partner, NI, to conduct a live demonstration of wireless communication utilizing this revolutionary mmWave coverage solution.
  • "Our XRifle Reflector and 5G mmW-Coverage solution provide a transformative answer to these challenges, enabling optimized mmWave deployment and connectivity in diverse settings."

HCPro announces two days of revenue cycle education and networking at the Revenue Integrity Symposium, presented by NAHRI, September 18-19 in Charlotte, North Carolina

Retrieved on: 
Monday, May 22, 2023
Maintenance, Communication, Education, RIS, Medicare, Customer service, Sheraton, National Association, Fortune 500, Revenue, Health insurance, Pharmaceutical industry, Management

BRENTWOOD, Tenn., May 22, 2023 /PRNewswire-PRWeb/ -- HCPro is excited to announce two days of revenue integrity and revenue cycle education at the Revenue Integrity Symposium (RIS), September 18–19, 2023, at the Sheraton Charlotte in North Carolina. Presented by the National Association of Healthcare Revenue Integrity (NAHRI), the symposium specializes in all things revenue cycle and revenue integrity, including denials management and chargemaster maintenance. It also provides attendees with high-quality educational sessions on Medicare compliance, maximizing revenue, enhancing workflows, and program design.

Key Points: 
  • Presented by the National Association of Healthcare Revenue Integrity (NAHRI), the symposium specializes in all things revenue cycle and revenue integrity, including denials management and chargemaster maintenance.
  • It also provides attendees with high-quality educational sessions on Medicare compliance, maximizing revenue, enhancing workflows, and program design.
  • BRENTWOOD, Tenn., May 22, 2023 /PRNewswire-PRWeb/ -- HCPro is excited to announce two days of revenue integrity and revenue cycle education at the Revenue Integrity Symposium (RIS), September 18–19, 2023, at the Sheraton Charlotte in North Carolina.
  • Presented by the National Association of Healthcare Revenue Integrity (NAHRI), the symposium specializes in all things revenue cycle and revenue integrity, including denials management and chargemaster maintenance.

ESMA calls for legislative amendments to prevent undue costs in funds

Retrieved on: 
Thursday, May 18, 2023
Steps, Industry, European Securities and Markets Authority, Civil service commission, Opinion, Policy, RIS, European Commission, Thema International Fund, UCITS, ESMA, Cryptocurrency, EU

ESMA calls for legislative amendments to prevent undue costs in funds

Key Points: 
  • ESMA calls for legislative amendments to prevent undue costs in funds
    The European Securities and Markets Authority (ESMA), the EU’s financial markets regulator and supervisor, has published an Opinion to the European Commission with suggested clarifications of the legislative provisions under the UCITS Directive and the AIFMD relating to the notion of “undue costs”.
  • Verena Ross, Chair of ESMA, said:
    “If we want to enhance retail investors’ participation in capital markets, we should ensure that the expected return of investment products isn’t impacted by undue costs.
  • With its Opinion to the European Commission on undue costs in funds, ESMA calls for legislative amendments to the UCITS Directive and the AIFMD.
  • By further harmonising the notion of undue costs among Member States, the proposal aims at preventing investors from being charged with undue costs and ensuring appropriate compensation for investors."

Avalo to Present at ATS 2023 Respiratory Innovation Summit

Retrieved on: 
Monday, May 15, 2023
ATS, COPD, Asthma, RIS, Therapy, American Thoracic Society, Rare-earth element, Pharmaceutical industry

WAYNE, Pa. and ROCKVILLE, Md., May 15, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, will attend and present at the ATS 2023 Respiratory Innovation Summit (RIS), hosted by the American Thoracic Society, on May 19-20, 2023 in Washington, DC.

Key Points: 
  • WAYNE, Pa. and ROCKVILLE, Md., May 15, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, will attend and present at the ATS 2023 Respiratory Innovation Summit (RIS), hosted by the American Thoracic Society, on May 19-20, 2023 in Washington, DC.
  • Dr. Neil will present on AVTX-002 in non-eosinophilic asthma during Showcase One: Asthma, COPD, and Airway Inflammation Innovators at 8:30am ET on Saturday, May 20, 2023.

Avalyn Pharma Showcasing Therapeutic Approach and Clinical Status at ATS 2023 and the Respiratory Innovation Summit (RIS)

Retrieved on: 
Thursday, May 11, 2023
Partnership, Week, ATS, RIS, PPF, Marriott Marquis, Research, Pulmonary fibrosis, American Thoracic Society, PAR, MD, Patient, Health, IPF, Washington Marriott Marquis, OLE, Idiopathic pulmonary fibrosis, Safety, ATLAS, Pharmaceutical industry

SEATTLE, May 11, 2023 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing inhaled therapies to treat life-threatening pulmonary diseases, today announced that the company will be participating in the upcoming American Thoracic Society (ATS) annual meeting and its associated Respiratory Innovation Summit (RIS), which are being held at the Marriott Marquis in Washington, DC. During RIS, Lyn Baranowski, Avalyn’s CEO, will moderate a discussion among a panel of experts from the ATS Public Advisory Roundtable (PAR), a public-private partnership designed to advance educational, research, patient care, and advocacy goals; and will separately present a corporate overview about Avalyn during the RIS company showcase. In addition, Felix Woodhead, MD PhD, senior medical director at Avalyn, is presenting long-term tolerability data from the AP01-005 open-label extension (OLE) trial during ATS, which is taking place from May 19-24, 2023.

Key Points: 
  • SEATTLE, May 11, 2023 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. , a clinical-stage biopharmaceutical company developing inhaled therapies to treat life-threatening pulmonary diseases, today announced that the company will be participating in the upcoming American Thoracic Society (ATS) annual meeting and its associated Respiratory Innovation Summit (RIS), which are being held at the Marriott Marquis in Washington, DC.
  • In addition, Felix Woodhead, MD PhD , senior medical director at Avalyn, is presenting long-term tolerability data from the AP01-005 open-label extension (OLE) trial during ATS, which is taking place from May 19-24, 2023.
  • Data presented at ATS will include safety and tolerability findings at Week 48 for the AP01-naive IPF and PPF patients recruited into the OLE.
  • Additionally, the presentation will include long-term efficacy data on patients who continued into the OLE study from the ATLAS study, some of whom have been on therapy for more than 3 years.

Aerami Therapeutics to Present Pharmacokinetic Data Supporting AER-901 (Inhaled Imatinib) for Pulmonary Hypertension at the 2023 American Thoracic Society (ATS) International Conference

Retrieved on: 
Thursday, May 11, 2023
Inflammation, PAH, ATS, Infection, RIS, CMAX, Lung, Washington Marriott Marquis, American Thoracic Society, International Conference on Nuclear Disarmament, Oslo, 2008, MD, Washington Convention Center, Walter, Orthostatic hypertension, Pulmonary hypertension, Therapy, Conference, Pharmaceutical industry

These results, presented by Aerami Chief Medical Officer Gary Burgess, MD, demonstrate the potential to achieve therapeutic lung levels with low inhaled doses of AER-901.

Key Points: 
  • These results, presented by Aerami Chief Medical Officer Gary Burgess, MD, demonstrate the potential to achieve therapeutic lung levels with low inhaled doses of AER-901.
  • AER-901 is entering Phase 2 clinical development for two serious and rare forms of pulmonary hypertension – pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
  • The presentation will take place during the “Showcase Four: Inflammation, Infectious Disease and Other Innovators” session at 2pm EST on May 20.
  • For more information about the ATS International Conference, please visit https://conference.thoracic.org/ .

Polarean to be a featured company at 2023 ATS Respiratory Innovation Summit

Retrieved on: 
Wednesday, May 3, 2023
AIM, ATS, RIS, Xe, Research, Doctor of Philosophy, Pulmonology, Government, Annals of the American Thoracic Society, Health, Conference, Management, Pharmaceutical industry

Durham, N.C., May 03, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging technology company, has been selected as one of the featured companies as a poster presenter at the American Thoracic Society’s (“ATS”) 2023 Respiratory Innovation Summit (“RIS"), taking place 19-20 May in Washington D.C.

Key Points: 
  • Durham, N.C., May 03, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging technology company, has been selected as one of the featured companies as a poster presenter at the American Thoracic Society’s (“ATS”) 2023 Respiratory Innovation Summit (“RIS"), taking place 19-20 May in Washington D.C.
  • The Respiratory Innovation Summit unites innovators, investors, clinicians, and advocacy groups who work in the field of pulmonary medicine.
  • The meeting historically attracts more than 275 global leaders representing all facets of the respiratory industry, including start-ups, venture capital, government, academia, and clinicians.
  • Following the Respiratory Innovation Summit, Polarean will be exhibiting at the 2023 ATS International Conference, taking place 21-24 May.

Global Cloud-based Medical Imaging Informatics Markets, 2022-2023 & 2026: Focus on Cloud-based Storage & Distribution Solutions, Cloud-based Diagnostic Informatics, and Cloud-based Workflow Solutions

Retrieved on: 
Thursday, April 27, 2023
Informatics, COVID-19, Radiological information system, Diagnosis, RIS, Cardiology, Investment, Big data, Radiology, Software, Medical imaging, Cloud

The report overviews the global cloud-based medical imaging informatics market in this research service, with a 5-year revenue forecast from 2022 to 2026.

Key Points: 
  • The report overviews the global cloud-based medical imaging informatics market in this research service, with a 5-year revenue forecast from 2022 to 2026.
  • The analyst segments the study forecast into Cloud-based Storage & Distribution Solutions, Cloud-based Diagnostic Informatics, and Cloud-based Workflow Solutions.
  • There is a growing need for cost-effective medical imaging informatics solutions that can perform more efficient image storage, distribution, analysis, and diagnosis with a faster turnaround time for results.
  • Due to all these factors, cloud-based medical imaging solutions are advancing and becoming an alternative to on-premises solutions.

ADLINK launches powerful MLC-M medical panel PCs with 11th generation Intel® Core™ processors

Retrieved on: 
Monday, April 17, 2023
PCAP, FCC, IP54, RIS, ANSI, ADLINK, UL, Intensive care medicine, HIS, Nurses station, Operating, MLC, Documentation, Vital signs, Patient, Risk, Dust, Diagnosis, System, OEM, Conference, PDMS, Medical device

SAN JOSE, Calif.,  April 17, 2023 /PRNewswire-PRWeb/ -- Summary:

Key Points: 
  • ADLINK Technology Inc., a global leader in edge computing, is showcasing its new series of MLC-M medical panel PCs at the HIMSS Global Health Conference in Chicago (Booth 6908).
  • Particularly light and slim, yet extremely powerful, the MLC-M is ideal for mobile use on medical carts or at nursing stations.
  • 11th generation Intel® Core™ processors provide the computing performance needed to effortlessly run high-resolution image processing software, as well as documentation applications such as HIS, RIS, and PDMS.
  • In addition to demonstrating the new MLC-M medical panel PC, ADLINK will be focusing on surgical monitors for operating and procedure rooms; and a compact, GPU-enabled medical box PC.